Maureen C Castillo, MA, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4006 Zuni St, Denver, CO 80211 Phone: 720-331-2354 |
Solace Healthcare, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 495 Uinta Way, Suite 140, Denver, CO 80230 Phone: 303-432-8487 |
Katie O'keefe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 495 Uinta Way Ste 140, Denver, CO 80230 Phone: 303-432-8487 |
Mrs. Leah Kristine Stewart Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St Fl 11, Denver, CO 80203 Phone: 720-423-2636 |
Lia Mancuso, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4740 Willow St Apt 304, Denver, CO 80238 Phone: 402-216-3888 |
Janette Turner, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Cherry Creek South Dr Ste 710, Denver, CO 80246 Phone: 303-432-8487 |
Kelsey Anne Powell, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4540 W 10th Ave, Denver, CO 80204 Phone: 720-424-8300 |
Margaret Fitzgerald Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St Fl 11, Denver, CO 80203 Phone: 720-423-2660 |
Lori Penwell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7350 Broadway, Denver, CO 80221 Phone: 303-853-1130 |
Yulia Liptsena Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 E 12th Ave Apt 309, Denver, CO 80203 Phone: 720-934-8634 |
Anna Eloyse Meihaus, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4500 E Cherry Creek South Dr Ste 710, Denver, CO 80246 Phone: 303-432-8487 |
Jennifer Parsons Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 495 Uinta Way, Denver, CO 80230 Phone: 303-432-8487 |
Sarah Alene Bookout Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4280 Hale Pkwy, Denver, CO 80220 Phone: 303-322-1871 |
Lauren Salm, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2921 Champa St Apt A, Denver, CO 80205 Phone: 505-363-3498 |
Lexi Ward Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1860 N Lincoln St Fl 11, Denver, CO 80203 Phone: 863-634-9103 |
Abby Friedman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2001 N High St, Denver, CO 80205 Phone: 720-413-3974 |
Christina Perkins, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 601 E 18th Ave Ste 130, Denver, CO 80203 Phone: 303-315-1278 |
Burke Speech Pathology Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3160 W 29th Ave, Denver, CO 80211 Phone: 303-503-9474 |
Ms. Caitlyn Alyssa Quin, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3401 Quebec St Ste 3500, Denver, CO 80207 Phone: 720-706-3396 |
Olivia Betulia, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 695 S Colorado Blvd Ste 20103, Denver, CO 80246 Phone: 303-360-0727 |
News Archive
Like a slumbering dragon, HIV can lay dormant in a person's cells for years, evading medical treatments only to wake up and strike at a later time, quickly replicating itself and destroying the immune system.
The Journal of Public Health Management and Practice today announced it is publishing a special issue addressing the increasing impact of the economic recession on public health agencies.
A drug approved to treat certain types of cancer has shown promising results in the treatment of patients with scleroderma, according to results from an open-label Phase II trial. While the drug's efficacy must be demonstrated in a Phase III trial, the gold standard for testing a drug, researchers are optimistic that Gleevec- (imatinib) could potentially be a weapon against the chronic connective tissue disease for which a treatment has remained elusive.
Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 - the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.
Oregon and Utah have waiver requests pending. Meanwhile, in Tennessee, steep Medicaid cuts are leading to the sale of some hospitals. And, in Arizona, a judge will soon decide whether health coverage should be restored for some low-income state residents whose health insurance ceased as a result of budget cuts.
› Verified 1 days ago